from Reuters: Business News http://ift.tt/2F2iMA5
Wednesday, February 28, 2018
Valeant revenue forecast misses estimates as competition heats up
(Reuters) - Valeant Pharmaceuticals' forecast for 2018 revenue fell below Wall Street estimates, as the company faces intensifying competition for some of its major products.
from Reuters: Business News http://ift.tt/2F2iMA5
from Reuters: Business News http://ift.tt/2F2iMA5
Related Posts:
Stock futures point to a green Christmas, despite partial shutdown- Hyundai sees Russia auto market growth slowing in 2019
- Brent crude edges up, but concern over demand limits gains
- Oil rises on signs recent low prices crimping U.S. output; but economic worries weigh
- AXA's Swiss employees mistakenly get double December pay
0 comments:
Post a Comment